High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

ObjectiveSingle inhaler triple therapy is widely used in Chronic Obstructive Pulmonary Disease (COPD) and asthma. This research aimed to analyze adverse events (AEs) associated with Budesonide/Glycopyrronium/Formoterol Fumarate (BUD/GLY/FOR) and Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/V...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhishen Ruan, Chunbin Wang, Shasha Yuan, Yiling Fan, Bo Xu, Xiaodong Cong, Dan Li, Qing Miao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
COPD
asthma
single-inhaler triple therapy
FAERS
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1460407/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1460407/full

Similar Items